Related Experiment Video
Updated: May 20, 2025

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations
Published on: February 2, 2024
[How adults with cerebral palsy are treated]
Anne Christina Rasmussen1, Jørgen Feldbæk Nielsen1,2, Jens Bo Nielsen3,4
1Hammel Neurorehabilitation Centre and University Research Clinic (HNURC).
Denmark lacks specialized public services for adults with cerebral palsy (CP). This review proposes a clinical habilitation model to improve complex care for individuals with CP, addressing multimorbidity and functional decline.
Area of Science:
- Neurology
- Rehabilitation Medicine
- Public Health Policy
Background:
- Adults with cerebral palsy (CP) face complex healthcare needs.
- Current treatment in Denmark lacks specialized, tax-funded services.
- Existing care involves multiple social and healthcare systems.
Purpose of the Study:
- To review the current treatment status for adults with CP in Denmark.
- To propose a clinical habilitation model for systematized care.
- To inspire clinical reasoning across medical specialties for CP management.
Main Methods:
- Literature review of current treatment practices.
- Analysis of healthcare and social service involvement.
- Development of a proposed clinical habilitation model.
Main Results:
- No dedicated public, tax-funded specialized services for adults with CP in Denmark.
- Complexities include cerebral developmental disorders, multimorbidity, and functional decline.
- A stepwise clinical habilitation model is proposed.
Conclusions:
- A structured habilitation model is needed to optimize care for adults with CP.
- The proposed model aims to enhance clinical reasoning and interdisciplinary collaboration.
- Systematized care can address the multifaceted needs of this population.
More Related Videos
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

